Connect with us

COVID19

COVID-19: 10 States Account For 75% Cases In India

Maharashtra continues to top this list. It alone contributed more than 21,000 cases yesterday.

Published

on

Graphic: PIB, GoI

NEW DELHI: A total of 86,508 new cases of COVID-19 infections have been reported in the last 24 hours in India. Of these at least 75% confirmed cases are found to be concentrated from 10 States/UTs.

For the sixth consecutive day, the number of new confirmed cases has been lower than the new recoveries. India posted 81.55 per cent of recoveries while the fatality rate stood at 1.59 per cent, the data from the Ministry of Health and Family Welfare said.

Maharashtra continues to top this list. It has alone contributed more than 21,000 cases.

Graphic: PIB, GoI

It is followed by Andhra Pradesh and Karnataka with more than 7,000 and 6,000 cases respectively.


1,129 deaths have been registered in the past 24 hours.

10 States/UTs account for 83% of the deaths in the last 24 hours due to COVID.

Maharashtra reported 479 deaths followed by Uttar Pradesh and Punjab with 87 and 64 deaths, respectively.


India has substantially ramped up its testing infrastructure across the country. As on date, there are 1810 labs including 1082 government and 728 private labs.

11,56,569 tests were conducted in the past 24 hours. The total number of tests has crossed 6.74 cr today.

Recovery rate continues to rise, crosses 81%

With its focussed strategies and effective, coordinated and proactive measures, India is reporting a steep increase in recoveries.

New recoveries in India have exceeded the new cases for the fifth consecutive day. 89,746 recoveries have been registered in the last 24 hours in the country, whereas the number of new confirmed cases stands at 83,347. With this, the total number of recoveries are 45,87,613. The Recovery Rate is 81.25% today.


India has the highest recovered cases in the world. It contributes 19.5% to the global recoveries. As India records more recoveries than the new cases, many States/UTs follow the suit. 17 States/UTs have more new recoveries than new cases.

Continue Reading
Comments

COVID19

COVID-19: Clinical Trial Of Ayurvedic Remedy Shows Encouraging Results

Over 85% of patients on the natural protocol tested negative for coronavirus on day 5.

Published

on

MUMBAI (Maharashtra): A groundbreaking interim report on a clinical trial being conducted in three hospitals has shown that Covid-19 patients on natural treatment are resolving most symptoms earlier than those on conventional medicines. The interim report on a combination treatment of an Ayurvedic remedy called ‘Immunofree’ by Corival Life Sciences, and Nutraceutical called ‘Reginmune’ by Biogetica have shown exceptional results as against the present government SOP of conventional medicines for coronavirus treatment.

When compared with conventional treatments for COVID-19, Ayurvedic treatment has shown quicker improvement too. 86.66 per cent of patients undergoing a natural treatment tested negative by the fifth day vs 60 per cent patients on conventional treatment.

On the 10th day, all patients tested negative for the virus after Ayurvedic treatment.

Furthermore, numerous tests such as C reactive protein, Procalcitonin, D Dimer and RT-PCR for novel coronavirus are also showing 20 to 60 per cent better improvement for the natural treatment, when compared to conventional treatment.


Numerous subjective endpoints such as body pain and fatigue are also leaning towards natural treatment. Both Clinician’s Global Assessment of Symptoms and Subject’s Global Assessment of Symptoms clearly showed improvements on both arms showing more significant data in the test group.

The three hospitals where Ayurvedic clinical trials are taking place in India are Government Medical Hospital, Srikakulam Andhra Pradesh; Parul Sevashram Hospital, Vadodara, Gujarat, and Lokmanya Hospital Pune, Maharashtra.

The conventional treatment in use depends on the severity of the patient and includes HCQ, Azithromycin, Favipiravir and Cetirizine. This trial also has broader inclusion criteria than others conducted on natural medicine as it includes patients up to 70 years old, with low oxygen saturation and co-morbidities.


It is significant to note that none of the patients on the natural treatment progressed past moderate, needed ventilators or had any adverse events. These precedent-setting results have led to accelerated enrolment into this trial and statistically significant results should be ready by month-end.

Continue Reading

COVID19

COVID-19: IIT Kharagpur Develops Telemedicine Tech For Corona Homecare

The system is accessible by any standard internet browser and also from a mobile device.

Published

on

KHARAGPUR (West Bengal): Amid the world, and India, struggling with the mayhem caused by COVID-19 pandemic. researchers at IIT Kharagpur’s Department of Computer Science & Engineering have developed a telemedicine system, iMediX.

The system integrates homecare with healthcare services from the hospital. Considering the emergent needs due to the pandemic, the system facilitates critical health care support to the patients at their doorsteps through remote consultation by a physician.

The system is accessible by any standard internet browser and also from a mobile device.

In this system, a patient signs up to get an account by providing his/her Email ID or Mobile number. Then the patient can make a request for consultation by choosing a Department of the hospital, entering the chief complaints and uploading necessary scanned medical records. The hospital administration processes the request and assigns a doctor. The doctor after logging in sets an appointment date and time for the patient and the system communicates the information to the patient by Email and SMS. On the day of the visit, the doctor consults the patient using video conferencing and advises the patient by writing a prescription, which is sent by Email to the patient. The patient can also download the prescription from his or her account.


Prof. Jayanta Mukhopadhyay, the lead researcher in this field remarked, “As the number of cases of home isolation and home quarantine is increasing, the system will cater to the needs of the present situation. It would be useful also to follow up and treat aged patients.”

iMedX is being adopted for public use right at its home, IIT Kharagpur on-campus healthcare system.

Director, Prof. V K Tewari stated, “In April we had announced eight R&D projects for providing COVID healthcare services. This telemedicine project is the key among them, especially, keeping in mind its effectiveness in our own community. When our campus will start operating in full strength close to 30000 people including students would be in need of healthcare services and this technology will reduce over-exposure of the healthcare staff while efficiently catering to the population. While we are promoting physical distancing, it seems only appropriate to introduce this digital platform to meet the healthcare needs of the campus community effectively. We are creating user accounts for our medical cardholders who can avail the consultation facility home through video conferencing”.

The software was launched on October 2, 2020, on the occasion of Gandhi Jayanti and will be integrated at the Dr B. C. Roy Technology Hospital of the Institute which provides emergency healthcare services for the campus residents and employees, confirmed the office of Principal Medical Officer Dr Samir Dasgupta.


Deputy Director, Prof. S K Bhattacharyya remarked, “Since we have a large number of OPD patients, it will be extremely beneficial to them as the movement to the hospital is extremely difficult for them. Also, for our students, the waiting time at the hospital will get reduced as this will be very helpful to them.”

A base model was installed at Swasthya Bhawan, Govt. of West Bengal on trial basis. Field trials are also underway for the base model at Bangladesh.

Director Tewari further shared his plan to expand the use of this technology to the people outside the campus through the upcoming super-speciality hospital of IIT Kharagpur.

The researchers are already in touch with healthcare MSMEs for commercialization of the copyrighted version of the technology.

Continue Reading

COVID19

COVID-19: 6Cr Indians Likely Exposed To Corona – 2nd ICMR Sero-Survey

Urban slum & non-slum areas have a higher prevalence of Corona infection than rural areas.

Published

on

NEW DELHI: ICMR’s second sero-survey findings released on Tuesday has revealed that one in 15 individuals aged 10 years and above were estimated to be exposed to SARS-CoV2 by August, showing that a considerable population is still susceptible to COVID-19.

Briefing media on Tuesday, DG ICMR Dr Balram Bhargava said, 6.6 per cent of over 29 thousand people, aged 10 and above, surveyed from 17th August to 22nd September showed evidence of past exposure to COVID-19 and 7.1 per cent of the adult population, aged 18 and above, also showed evidence of past exposure to it.

He said lockdown, containment and behavioural change at the population level have effectively checked the potential spread of SARS-CoV2.


Dr Bhargava said the risk in urban slums was twice than that in non-slum urban areas and four times the risk in rural settings.

He said that the second sero-survey was conducted in the same 700 villages and wards from 70 districts from 21 states which were covered during the first survey.

But this time, it surveyed different households and individuals.


The ICMR DG said, since a large proportion of the population is still susceptible, prevention fatigue has to be avoided and the 5T strategy — test, track, trace, treat, technology — has to be adhered to.

Continue Reading

Most Read This Month

error: Content on this news portal is protected!